Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

NOURIANZ (istradefylline) for the Treatment of Parkinson’s Disease

NOURIANZ (istradefylline) is a selective adenosine A2A receptor antagonist. Credit: Sotnikov Ivan / Shutterstock.



  • Nourianz
  • Nourianz
  • Nourianz
Close
Close
Close

Go Top